These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1910642)

  • 1. Renal effects of calcium antagonists in diabetes mellitus. An overview of studies in animal models and in humans.
    Bakris GL
    Am J Hypertens; 1991 Jul; 4(7 Pt 2):487S-493S. PubMed ID: 1910642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria.
    Brown SA; Walton CL; Crawford P; Bakris GL
    Kidney Int; 1993 Jun; 43(6):1210-8. PubMed ID: 8391095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
    Dworkin LD; Benstein JA; Parker M; Tolbert E; Feiner HD
    Kidney Int; 1993 Apr; 43(4):808-14. PubMed ID: 8479116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease.
    Ritz E; Orth SR; Strzelczyk P
    J Hypertens Suppl; 1997 Mar; 15(2):S21-6. PubMed ID: 9218194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
    Kvam FI; Ofstad J; Iversen BM
    Am J Physiol; 1998 Oct; 275(4):F576-84. PubMed ID: 9755129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T; Kanno Y; Hayashi K; Konishi K
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A; Brunner HR; Waeber B; Burnier M
    J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
    Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
    Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the renal action of pranidipine in the rat.
    Nagahama T; Hayashi K; Fujiwara K; Ozawa Y; Saruta T
    Arzneimittelforschung; 2000 Mar; 50(3):248-53. PubMed ID: 10758776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
    Mackie FE; Meyer TW; Campbell DJ
    Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of benidipine on glomerular hemodynamics and proteinuria in patients with nondiabetic nephropathy.
    Morikawa T; Okumura M; Konishi Y; Okada N; Imanishi M
    Hypertens Res; 2002 Jul; 25(4):571-6. PubMed ID: 12358143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.
    Hayashi K; Ozawa Y; Fujiwara K; Wakino S; Kumagai H; Saruta T
    Am J Nephrol; 2003; 23(4):229-44. PubMed ID: 12840599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.